Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MarketWatch

Novo Nordisk’s stock rallied after drugmaker reveals deal with OpenAI

Novo Nordisk’s stock rallied after drugmaker reveals deal with OpenAI
ShareXFacebook

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce.

M

Source

MarketWatch

Read full article at MarketWatch

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement